Beta Bionics, Inc. (BBNX): Kapitalisasi marang pendapatan
The estimated price-to-sales ratio for Beta Bionics Inc (BBNX) demonstrates the impact of patent protection for algorithms and stringent FDA requirements on the share price. The current 7.00 metric determines the parameter's status amid the release of autonomous AI pumps for diabetics. However, operational expenses associated with expanding the distribution network and uncertainty regarding insurance company payouts are amplifying the chart's volatility.
Rincian analitis perusahaan Beta Bionics Corp (BBNX)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Beta Bionics Inc|BBNX - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas iLet Bionic Pancreas|BBNX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Beta Bionics Corp|BBNX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Beta Bionics|Rasio jangkoan perantara betabionics.com
- data bathi lan kelipatan valuasi:
BBNX - Bathi resik|Bathi resik sing dikarepake Beta Bionics Inc|BBNX - Rasio rega marang bathi|Pangali forward rega marang bathi Beta Bionics, Inc.|BBNX - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Beta Bionics Corp|BBNX - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Beta Bionics|BBNX - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan betabionics.com|BBNX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Beta Bionics Inc
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:BBNX betabionics.com
The P/S multiple relates the market capitalization of Beta Bionics Inc (BBNX) to its annual revenue, measuring the cost of each dollar of sales to determine the extent of the asset's overvaluation. By analyzing this price-to-sales ratio, an investor can evaluate the effectiveness of the medical device commercial launch and verify whether actual demand growth justifies the market's advance confidence in the young management team.
Pesaing Beta Bionics Inc
BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|IRMD: Rasio rega marang pendapatan|EMBC (Embecta Inc.) - Kapitalisasi marang pendapatan|Tandem Corp - Rasio kapitalisasi pasar marang pendapatan|AXGN (AxoGen, Inc.) - Multiplikator P/S|Rega marang dodolan si-bone.com SIBN|Rasio rega marang pendapatan Orthofix (OFIX)|Bioventus Inc (BVS) - Multiplikator rega marang pendapatan|OrthoPediatrics - Kapitalisasi marang pendapatan|Multiplikator P/S Treace Corp TMCI|Strata Critical Medical Inc - Multiplikator P/S|Koefisien rega marang pendapatan carlsmed.com CARL|RxSight (RXST) - Rasio rega marang pendapatan|Rasio rega marang dodolan CLPT (ClearPoint Neuro)|Rasio rega marang pendapatan Stereotaxis Corp|Kapitalisasi marang pendapatan Neuronetics, Inc (STIM)|Multiplikator P/S SGHT|OBIO - Rega marang dodolan|Rasio rega marang pendapatan Anika Therapeutics, Inc. ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical, Inc. - Kapitalisasi marang volume dodolan|XTNT: Multiplikator P/S|NMTC (n1mtc.com) - Rasio rega marang pendapatan|MODD (Modular Medical Inc) - Multiplikator P/S|Rega marang dodolan Myomo Inc. MYO|Kapitalisasi marang pendapatan COCH (Envoy Medical, Inc)|Kapitalisasi marang volume dodolan VVOS|Multiplikator P/S NVNO (enVVeno Medical)|Multiplikator P/S Sintx Technologies Inc SINT|TNON: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan LFWD (ReWalk Robotics)|AMIX: Multiplikator P/S|IVF (INVO Fertility Corp) - Rasio rega marang pendapatan|BBLG (Bone Biologics) - Multiplikator P/S|axonics.com (AXNX) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan BIOLASE (BIOL)|DYNT - Rega marang dodolan|Rasio rega marang pendapatan Paragon 28 FNA|INVO: Rasio kapitalisasi marang pendapatan
